MedTrace Logo

Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF

NCT01303068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-01-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if inhaled urea can be used to detect the presence of Pseudomonas Aeruginosa in the lungs

Conditions

Interventions

DEVICE

13C urea breath test Kit

20 and 50 mg, 13C urea breath test: urea nebulizer solution to detect Pseudomonas

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Hengameh Raissy, PharmD · UNM

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-15
Primary Completion
2014-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01303068 on ClinicalTrials.gov